Article
The Use of Patient-Derived Organoids in the Study of Molecular Metabolic Adaptation in Breast Cancer
29 Sept 2024
Abstract excerpt
Around 13% of women will likely develop breast cancer during their lifetime. Advances in cancer metabolism research have identified a range of metabolic reprogramming events, such as altered glucose and amino acid uptake, increased reliance on glycolysis, and interactions with the tumor microenvironment (TME), all of which present new opportunities for targeted therapies. However, studying these metabolic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
